Health Insurer Stocks Surge on 2027 Medicare Rate
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- CMS finalized a 2.48% Medicare Advantage rate increase for 2027, a dramatic improvement over the 0.09% proposed in late January that had shocked investors and dragged down the Dow.
- UnitedHealth (UNH) jumped 9.4%—making it the best-performing Dow stock—while Humana (HUM) rose 7.9%, CVS Health gained 6.7%, Elevance Health climbed 3.0%, and Centene added 2.6%.
- Molina Healthcare was the lone decliner in the sector, closing 1.3% lower despite the broader rally.
- The 2.48% rate is still lower than the 5.06% finalized for 2026 and 3.70% for 2025, meaning the rally reflects relief from a worst-case scenario rather than a generous payment environment.
- UnitedHealth and Humana shares had tanked in late January after the initial 0.09% proposal, even dragging down the Dow Jones Industrial Average at the time.
- The gap between proposed and final rates reflected higher-than-expected Q4 medical utilization claims data and CMS's decision not to advance a new risk-adjustment model for 2027.
- Raymond James analyst Chris Meekins called the sector "a beaten-down industry on the cusp of potentially two years of earnings growth."
Why it matters: UnitedHealth, the largest Medicare Advantage player, gained 9.4% and led the Dow after intense insurer lobbying pushed CMS to raise its proposed 2027 rate from a punishing 0.09% to 2.48%. The 2.48% is still below 2026's 5.06%, so investors are buying relief from a feared scenario, not a tailwind. With medical utilization surging and the sector beaten down, the new rate opens the door to "potentially two years of earnings growth," per Raymond James.
